As the most commonly sexually transmitted disease worldwide, human papillomavirus
(HPV) infections are associated with significant morbidity and mortality. HPV infections most …

Background To assess the impact of a quadrivalent human papillomavirus vaccine (4HPV)
in women at increased risk of genital warts (GWs) acquisition. Methods The study was …

Objective: This study aimed to determine if the Australian human papillomavirus (HPV)
vaccination programme has had a population impact on presentations of genital warts …

Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts (GW)
in women aged 14–23 years and to estimate the incidence of GW in the whole population …

Human papillomavirus (HPV) is one of the most common sexually transmitted diseases
(STDs) and is frequently presented clinically as anogenital warts in both males and females …

Although much has been learned about the biology of HPV during the last decade, little
progress has been made in the development of rational and effective patient management …

Genital warts are a cosmetic nuisance. They are caused by low-risk human papillomavirus
types, have no oncogenic potential and are not linked to cervical cancer. However, they …

The European Course on HPV Associated Pathology (ECHPV) was founded in 1990 by a
group of clinicians, pathologists, and virologists to teach important principles for the practice …

Background: The burden of anogenital warts will be a determining factor when making
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …